Literature DB >> 22688185

Influence of liver histopathology on transaminitis following total pancreatectomy and autologous islet transplantation.

Chirag S Desai1, Khalid M Khan, Felipe B Megawa, Horacio Rilo, Tun Jie, Angelika Gruessner, Rainer Gruessner.   

Abstract

BACKGROUND: In type 1 diabetics undergoing allogenic islet transplants, transaminitis and portal vein thrombosis (PVT) after transhepatic portal infusion of islets may be related to infusion pressure and the purity of islets. Complications of intraoperative portal infusion of islets in patients with chronic pancreatitis undergoing a total pancreatectomy (TP) and autologous islet transplant (AIT) and the relationship to liver histopathology have not been examined. AIM: The purpose of this study was to examine complications of intraportal infusion of autologous islets after TP.
METHODS: Data on 26 TP-AIT patients were analyzed.
RESULTS: Infusion of islets [mean 304,473 ± 314,557 islet equivalents, median volume 300 mL (50-600)] resulted in mean postinfusion PV pressure of 9.15 ± 10.09 cmH2O which correlated with infused islets equivalents (r (2) = 33.6, P = 0.002) and volume (r (2) = 30.4, P = 0.005). Of 23 patients undergoing liver biopsy, 8 (35 %) were normal, 10 (43 %) had steatosis, and 5 (22 %) periportal fibrosis. Peak alanine aminotransferase (ALT; median 1 day after infusion) differed among the three histologic groups (P = 0.025). The difference in ALT was statistically significant between steatosis (showed the greatest increase) and the other two groups, but not between the normal and fibrosis groups. No correlation was found between the portal pressure increase at infusion and other variables. Two patients that developed PVT on day 1 had the highest infusion pressures; a third occurred on day 5.
CONCLUSION: Preexisting liver pathology is a contributing factor in the rise in liver enzymes but does not correlate with development of PV thrombosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22688185     DOI: 10.1007/s10620-012-2264-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Prolonged survival of intraportal versus subrenal capsular transplanted islet allografts.

Authors:  P F Gores; F Rabe; D E Sutherland
Journal:  Transplantation       Date:  1987-05       Impact factor: 4.939

2.  Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis.

Authors:  Syed A Ahmad; Andrew M Lowy; Curtis J Wray; David D'Alessio; Kywran A Choe; Laura E James; Andreas Gelrud; Jeffrey B Matthews; Horacio L R Rilo
Journal:  J Am Coll Surg       Date:  2005-09-23       Impact factor: 6.113

3.  A morphologic study of intrahepatic portal-vein islet isografts.

Authors:  R C Griffith; D W Scharp; B K Hartman; W F Ballinger; P E Lacy
Journal:  Diabetes       Date:  1977-03       Impact factor: 9.461

4.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

Review 5.  Chronic pancreatitis.

Authors:  Joan M Braganza; Stephen H Lee; Rory F McCloy; Michael J McMahon
Journal:  Lancet       Date:  2011-04-02       Impact factor: 79.321

6.  Autologous islet transplantation to prevent diabetes after pancreatic resection.

Authors:  D C Wahoff; B E Papalois; J S Najarian; D M Kendall; A C Farney; J P Leone; J Jessurun; D L Dunn; R P Robertson; D E Sutherland
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

7.  Autotransplantation of dispersed pancreatic islet tissue combined with total or near-total pancreatectomy for treatment of chronic pancreatitis.

Authors:  A C Farney; J S Najarian; R E Nakhleh; G Lloveras; M J Field; P F Gores; D E Sutherland
Journal:  Surgery       Date:  1991-08       Impact factor: 3.982

8.  Intraportal and intrasplenic autotransplantation of pancreatic islets in the dog.

Authors:  E Kolb; R Ruckert; F Largiadèr
Journal:  Eur Surg Res       Date:  1977       Impact factor: 1.745

9.  Changes in liver enzymes after clinical islet transplantation.

Authors:  Ehab Rafael; Edmond A Ryan; Breay W Paty; Jose Oberholzer; Sharleen Imes; Peter Senior; Charlotte McDonald; Jonathan R T Lakey; A M James Shapiro
Journal:  Transplantation       Date:  2003-11-15       Impact factor: 4.939

10.  Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis.

Authors:  J S Najarian; D E Sutherland; D Baumgartner; B Burke; J J Rynasiewicz; A J Matas; F C Goetz
Journal:  Ann Surg       Date:  1980       Impact factor: 12.969

View more
  5 in total

1.  Islet autotransplantation in a patient with hypercoagulable disorder.

Authors:  Chirag S Desai; Khalid M Khan; Wanxing Cui
Journal:  World J Transplant       Date:  2016-06-24

2.  Trying to prevent the clogged drain: optimizing the yield and function of portal vein-infused islets.

Authors:  A N Balamurugan; Timothy L Pruett
Journal:  Dig Dis Sci       Date:  2013-05       Impact factor: 3.199

Review 3.  Use of anti-inflammatory agents in clinical islet cell transplants: A qualitative systematic analysis.

Authors:  Kristen R Szempruch; Oyshik Banerjee; Rebecca C McCall; Chirag S Desai
Journal:  Islets       Date:  2019       Impact factor: 2.694

Review 4.  What Is New with Total Pancreatectomy and Autologous Islet Cell Transplantation? Review of Current Progress in the Field.

Authors:  Xavier L Baldwin; Brittney M Williams; Beth Schrope; Chirag S Desai
Journal:  J Clin Med       Date:  2021-05-14       Impact factor: 4.241

5.  Effect of liver histopathology on islet cell engraftment in the model mimicking autologous islet cell transplantation.

Authors:  Chirag S Desai; Khalid M Khan; Xiaobo Ma; Henghong Li; Juan Wang; Lijuan Fan; Guoling Chen; Jill P Smith; Wanxing Cui
Journal:  Islets       Date:  2017-09-13       Impact factor: 2.694

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.